Baker McKenzie advised Minoryx Therapeutics on the deal. Clifford Chance advised the Neuraxpharm Group. Minoryx Therapeutics, a late-stage biotech company focused on the development of treatments...
You must be a Standard 1 Year member to access this content.
Baker McKenzie represented Alquiber Quality on the deal. Alquiber Quality, a leading company on flexible renting of vehicles and listed on BME Growth, announced the establishment...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised a syndicate of initial purchasers on the deal. Vía Célere Desarrollos Inmobiliarios, S.A. completed a €300 million 5.25% senior secured high yield bond issuance....
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised the Arranger and Dealers on the deal. Euskaltel S.A. executed the update of the €200 million Euro Commercial Paper Programme. The application has been...
You must be a Standard 1 Year member to access this content.
